Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Artículo en Inglés | MEDLINE | ID: mdl-26476437

RESUMEN

BACKGROUND: Most currently available active antidepressant drugs are selective serotonin/noradrenaline reuptake inhibitors. However, as their clinical efficacy is not immediate, long-term administration is often accompanied by substantial side effects, and numerous patients remain non- or partial responders. We have recently found that the synthetic neurosteroid derivative 3ß-methoxypregnenolone, which binds to the microtubule-associated protein-2, can provide a novel therapeutic approach in experimental model of depressive disorders in rats. To further validate the antidepressant-like efficacy of 3ß-methoxypregnenolone, we investigated effects of a longer treatment (4-week oral administration; 50mg/kg/d) in a nonrodent species, the tree shrew, exposed to psychosocial stress that elicits close-to-human alterations observed in patients with depressive disorders. METHODS: During the experimental period, physiological parameters were registered, including core body temperature and electroencephalogram, while animals were videotaped to analyze their avoidance behavior. Morning urine samples were collected for measurements of cortisol and noradrenaline levels. RESULTS: We found that treatment with 3ß-methoxypregnenolone abolished stress-triggered avoidance behavior and prevented hormone hypersecretion, hypothermia, and sleep disturbances, further suggesting its antidepressant-like efficacy. Comparative treatment with fluoxetine also prevented some of the physiological alterations, while the hypersecretion of cortisol and sleep disturbances were not or partially restored by fluoxetine, suggesting a better efficacy of 3ß-methoxypregnenolone. Alpha-tubulin isoforms were measured in hippocampi: we found that 3ß-methoxypregnenolone reversed the specific decrease in acetylation of α-tubulin induced by psychosocial stress, while it did not modify the psychosocial stress-elicited reduction of tyrosinated α-tubulin. CONCLUSIONS: Taken together, these data strongly suggest a potent antidepressant-like effect of 3ß-methoxypregnenolone on translational parameters.


Asunto(s)
Antidepresivos/farmacología , Pregnenolona/análogos & derivados , Estrés Psicológico/tratamiento farmacológico , Estrés Psicológico/fisiopatología , Administración Oral , Animales , Antidepresivos/sangre , Reacción de Prevención/efectos de los fármacos , Reacción de Prevención/fisiología , Temperatura Corporal/efectos de los fármacos , Temperatura Corporal/fisiología , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hidrocortisona/orina , Masculino , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Norepinefrina/orina , Pregnenolona/sangre , Pregnenolona/farmacología , Sueño/efectos de los fármacos , Sueño/fisiología , Conducta Social , Tubulina (Proteína)/metabolismo , Tupaiidae
2.
J Exp Med ; 199(3): 315-21, 2004 Feb 02.
Artículo en Inglés | MEDLINE | ID: mdl-14744996

RESUMEN

The V(D)J recombination/DNA repair factor Artemis belongs to the metallo-beta-lactamase (beta-Lact) superfamily of enzymes. Three regions can be defined within the Artemis protein sequence: (a) the beta-Lact homology domain, to which is appended (b) the beta-CASP region, specific of members of the beta-Lact superfamily acting on nucleic acids, and (c) the COOH-terminal domain. Using in vitro mutagenesis, here we show that the association of the beta-Lact and the beta-CASP regions suffices for in vivo V(D)J recombination of chromosome-integrated substrates. Single amino acid mutants point to critical catalytic residues for V(D)J recombination activity. The results presented here define the beta-Lact/beta-CASP domain of Artemis as the minimal core catalytic domain needed for V(D)J recombination and suggest that Artemis uses one or two Zn(II) ions to exert its catalytic activity, like bacterial class B beta-Lact enzymes hydrolyzing beta-lactam compounds.


Asunto(s)
Proteínas del Citoesqueleto/metabolismo , Reparación del ADN/genética , Proteínas Nucleares/genética , VDJ Recombinasas/metabolismo , beta-Lactamasas/metabolismo , Secuencia de Aminoácidos , Bacterias/enzimología , Bacterias/genética , Secuencia de Bases , Línea Celular , Línea Celular Transformada , Clonación Molecular , ADN Complementario/genética , Proteínas de Unión al ADN , Endonucleasas , Fibroblastos/citología , Fibroblastos/fisiología , Prueba de Complementación Genética , Humanos , Mutagénesis , Proteínas Nucleares/metabolismo , Proteínas Recombinantes/metabolismo , Piel/citología , Especificidad por Sustrato , Factores de Transcripción
3.
Pharmacol Ther ; 191: 190-206, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-29953900

RESUMEN

Neurosteroids are neuroactive brain-born steroids. They can act through non-genomic and/or through genomic pathways. Genomic pathways are largely described for steroid hormones: the binding to nuclear receptors leads to transcription regulation. Pregnenolone, Dehydroepiandrosterone, their respective sulfate esters and Allopregnanolone have no corresponding nuclear receptor identified so far whereas some of their non-genomic targets have been identified. Neuroplasticity is the capacity that neuronal networks have to change their structure and function in response to biological and/or environmental signals; it is regulated by several mechanisms, including those that involve neurosteroids. In this review, after a description of their biosynthesis, the effects of Pregnenolone, Dehydroepiandrosterone, their respective sulfate esters and Allopregnanolone on their targets will be exposed. We then shall highlight that neurosteroids, by acting on these targets, can regulate neurogenesis, structural and functional plasticity. Finally, we will discuss the therapeutic potential of neurosteroids in the pathophysiology of neurological diseases in which alterations of neuroplasticity are associated with changes in neurosteroid levels.


Asunto(s)
Enfermedades del Sistema Nervioso/fisiopatología , Plasticidad Neuronal/fisiología , Neurotransmisores/metabolismo , Animales , Deshidroepiandrosterona/biosíntesis , Deshidroepiandrosterona/metabolismo , Humanos , Enfermedades del Sistema Nervioso/terapia , Neurogénesis/fisiología , Neurotransmisores/biosíntesis , Pregnanolona/biosíntesis , Pregnanolona/metabolismo , Pregnenolona/biosíntesis , Pregnenolona/metabolismo
4.
Curr Opin Immunol ; 15(5): 592-8, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14499270

RESUMEN

V(D)J recombination not only comprises the molecular mechanism that insures diversity of the immune system but also constitutes a critical checkpoint in the developmental program of B and T lymphocytes. The analysis of human patients with severe combined immune deficiency (SCID) has enabled (and will enable in the future) the discovery of important factors involved in this reaction. The finding that the V(D)J recombinase apparatus includes components of the general DNA repair machinery of the cells has provided some new and interesting insights into the role of V(D)J recombination deficiency in the development of lymphoid malignancies, a hypothesis that has been tackled and proven in several animal models.


Asunto(s)
Modelos Animales de Enfermedad , VDJ Recombinasas/deficiencia , VDJ Recombinasas/inmunología , Animales , Proteínas de Unión al ADN/genética , Proteínas de Homeodominio/genética , Humanos , Ratones , Ratones Noqueados , Proteínas Nucleares , Inmunodeficiencia Combinada Grave/genética , Inmunodeficiencia Combinada Grave/inmunología
5.
Ann N Y Acad Sci ; 987: 150-7, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12727634

RESUMEN

V(D)J recombination constitutes a critical checkpoint in the development of the immune system as shown in several animal models as well as severe combined immune deficiency (SCID) condition in humans. We recently cloned the Artemis gene, whose mutations are responsible for RS-SCID, a condition characterized by an absence of both B and T lymphocytes and associated with increased sensitivity to ionizing radiations. Artemis is ubiquitously expressed and is localized in the nucleus. Artemis belongs to the metallo-beta-lactamase superfamily and defines a new group, beta-CASP, within this family. beta-CASP proteins are beta-lactamases acting on nucleic acids. While RS-SCID patients harbor Artemis loss-of-function mutations, we identified four patients with a combined immunodeficiency characterized by a low but detectable number of both B and T lymphocytes caused by hypomorphic mutations in the Artemis gene. Two of these patients developed aggressive B cell lymphomas, a condition that suggests Artemis may be considered a "caretaker" factor, similarly to the other V(D)J recombination/DNA repair actors.


Asunto(s)
ADN Nucleotidiltransferasas/fisiología , Reparación del ADN , Proteínas Nucleares/fisiología , beta-Lactamasas/metabolismo , ADN Nucleotidiltransferasas/metabolismo , Proteínas de Unión al ADN , Endonucleasas , Humanos , Tejido Linfoide/enzimología , Tejido Linfoide/metabolismo , Modelos Moleculares , Mutación , Proteínas Nucleares/química , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , VDJ Recombinasas
6.
Eur J Immunol ; 33(8): 2216-22, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12884296

RESUMEN

Enhancer alpha-dependent histone acetylation has been proposed as a molecular mechanism underlying the control of accessibility of recombination signal sequences along the TCRalpha locus. Here we show that chromatin acetylation along the first Jalpha segments is under the dependence of the T early alpha element (TEA), located upstream of TCRJalpha locus. The targeted deletion of TEA leads to an absence of histones H3 and H4 tail acetylation, while maintaining histone acetylation in the region spanning downstream Jalpha segments. During thymocyte maturation, TEA-dependent histone acetylation appears at immature single-positive stage, known to represent the stage of ValphaJalpha initiation. TEA-dependent histone acetylation of the most upstream Jalpha segments leads to enhanced DNA accessibility thus optimizing TCRJalpha usage and increasing Ag receptor diversity potential.


Asunto(s)
Sistemas de Transporte de Aminoácidos Básicos , Proteínas Portadoras/genética , Genes Codificadores de la Cadena alfa de los Receptores de Linfocito T , Histonas/metabolismo , Proteínas de la Membrana/genética , Acetilación , Animales , Secuencia de Bases , Cromatina/metabolismo , Reordenamiento Génico de la Cadena alfa de los Receptores de Antígenos de los Linfocitos T , Histonas/química , Ratones , Ratones Noqueados , Linfocitos T/inmunología , Linfocitos T/metabolismo
7.
J Immunol ; 171(7): 3605-11, 2003 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-14500657

RESUMEN

Ordered assembly of Ag receptor genes by VDJ recombination is a key determinant of successful lymphocyte differentiation and function. Control of gene rearrangement has been traditionally viewed as a result of complex reorganization of the nucleochromatin mediated by several nuclear factors. Selective recombination of the variable (V) genes to the diversity (D), but not joining (J), gene segments within the TCRbeta locus has been shown to be controlled by recombination signal (RS) sequences that flank the gene segments. Through ex vivo and in vitro recombination assays, we demonstrate that the Rag proteins can discriminate between the RS of the D and J genes and enforce selective D gene incorporation into the TCRbeta variable domain in the absence of other nuclear factors or chromatin structure. DNA binding studies indicate that discrimination is not simply caused by higher affinity binding of the Rag proteins to the isolated 12RS of the D as opposed to the J genes. Furthermore, we also demonstrate that the 12RS within the TCRbeta locus is functionally inferior to the consensus 12RS. We propose that selective gene segment usage is controlled at the level of differential assembly and/or stability of synaptic RS complexes, and that evolutionary "deterioration" of the RS motifs may have been important to allow the VDJ recombinase to exert autonomous control over gene segment use during gene rearrangement.


Asunto(s)
Diversidad de Anticuerpos/genética , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Reordenamiento Génico de la Cadena beta de los Receptores de Antígenos de los Linfocitos T/inmunología , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Recombinación Genética/inmunología , VDJ Recombinasas/genética , Línea Celular , Proteínas de Unión al ADN/aislamiento & purificación , Embrión de Mamíferos , Marcadores Genéticos/inmunología , Proteínas de Homeodominio/aislamiento & purificación , Humanos , Región de Unión de la Inmunoglobulina/genética , Región de Unión de la Inmunoglobulina/metabolismo , Región Variable de Inmunoglobulina/genética , Región Variable de Inmunoglobulina/metabolismo , Riñón/citología , Proteínas Nucleares , Especificidad por Sustrato/genética , Especificidad por Sustrato/inmunología , VDJ Recombinasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA